Is high-sensitivity C-reactive protein an effective screening test for cardiovascular risk?

Archives of Internal Medicine

Volumn 162, Issue 8, 2002, Pages 867-869

  Kushner, Irving ^a,b,c   Sehgal, Ashwini R ^a,b,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIAGNOSTIC VALUE; HUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; RELIABILITY; SCREENING TEST;

EID: 0037156465     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.8.867     Document Type: Article

References (30)

1. Serum C-reactive protein levels in disease
2. Acute-phase proteins and other systemic responses to inflammation
3. High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease
4. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
5. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications
6. Evaluating novel cardiovascular risk factors: Can we better predict heart attacks?
7. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening
8. C-reactive protein in the prediction of cardiovascular disease
9. Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: Assessment and implications for epidemiology
10. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults
11. Comparative study of C reactive protein and serum amyloid A protein in experimental inflammation
12. Acute phase response of serum amyloid A protein and C reactive protein to the common cold and influenza
13. Statins and the acute phase response
14. C-reactive protein (CRP) elevation can be caused by conditions other than inflammation and may reflect biologic aging
15. Determinants of C-reactive protein concentration in blood
16. Association between physical activity and markers of inflammation in a healthy elderly population
17. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging
18. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome
19. The effect of high-protein diets on coronary blood flow
20. Effect of alcohol consumption on systemic markers of inflammation
21. The role of inflammatory mediators in the biology of major depression: Central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection
22. Familial and genetic determinants of systemic markers of inflammation: The NHLBI Family Heart Study
23. Long-term effects of pravastatin on plasma concentration of C-reactive protein: The Cholesterol and Recurrent Events (CARE) Investigators
24. Effect of statin therapy on C-reactive protein levels: The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
25. Statins and C-reactive protein
26. Markers of inflammation as predictors in cardiovascular disease
27. C-Reactive protein and cardiovascular risk: Has the time come for screening the general population?
28. C-reactive protein, inflammation and atherosclerosis: Do we really understand it yet?
29. C-reactive protein - A screening test for coronary disease?